Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D King

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Postgraduate Medicine|September 1, 1996
Why we should treat chronic viral hepatitisP D King
The Oncologist|April 18, 2001
Hepatotoxicity of chemotherapyP D King, M C Perry
Seminars in Liver Disease|November 1, 1990
Drug-induced cholestasis: pathogenesis and clinical featuresP D King, B L Blitzer
Topics in Health Record Management|August 9, 1982
Requiring physicians to complete medical recordsW H Roach, P D King
European Journal of Immunology|April 1, 1989
Human tonsillar dendritic cell-induced T cell responses: analysis of molecular mechanisms using monoclonal antibodiesP D King, D R Katz
Missouri Medicine|December 1, 1994
A case of Whipple's disease in MissouriP D King, A D Havey
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Hepatic transport of rose bengal by perfused rabbit liver: the effect of albumin binding on the unidirectional rate constantsB A Luxon, P D King
Annals of Internal Medicine|February 21, 1998
Transjugular intrahepatic portosystemic shunt or sclerotherapy: which would you choose?J B Marshall, P D King
Immunology Today|June 1, 1990
Mechanisms of dendritic cell functionP D King, D R Katz
Gastroenterology Clinics of North America|December 1, 1995
Hepatotoxicity of chemotherapeutic and oncologic agentsP D King, M C Perry
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Postgraduate Medicine|September 1, 1996
Why we should treat chronic viral hepatitisP D King
The Oncologist|April 18, 2001
Hepatotoxicity of chemotherapyP D King, M C Perry
Seminars in Liver Disease|November 1, 1990
Drug-induced cholestasis: pathogenesis and clinical featuresP D King, B L Blitzer
Topics in Health Record Management|August 9, 1982
Requiring physicians to complete medical recordsW H Roach, P D King
European Journal of Immunology|April 1, 1989
Human tonsillar dendritic cell-induced T cell responses: analysis of molecular mechanisms using monoclonal antibodiesP D King, D R Katz
Missouri Medicine|December 1, 1994
A case of Whipple's disease in MissouriP D King, A D Havey
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1995
Hepatic transport of rose bengal by perfused rabbit liver: the effect of albumin binding on the unidirectional rate constantsB A Luxon, P D King
Annals of Internal Medicine|February 21, 1998
Transjugular intrahepatic portosystemic shunt or sclerotherapy: which would you choose?J B Marshall, P D King
Immunology Today|June 1, 1990
Mechanisms of dendritic cell functionP D King, D R Katz
Gastroenterology Clinics of North America|December 1, 1995
Hepatotoxicity of chemotherapeutic and oncologic agentsP D King, M C Perry
Pageof 7